Search results
Fennec Pharmaceuticals Inc (NASDAQ:FENC) to Post FY2024 Earnings of ($0.09) Per Share, Cantor...
ETF DAILY NEWS· 2 days agoCantor Fitzgerald analyst C. Duncan now anticipates that the company will post earnings of ($0.09) per share for the year, down from their prior forecast of $0.11. The consensus ...
Brokers Set Expectations for West Pharmaceutical Services, Inc.’s Q4 2024 Earnings (NYSE:WST)
ETF DAILY NEWS· 2 days agoWest Pharmaceutical Services, Inc. (NYSE:WST – Free Report) – Analysts at Zacks Research lifted their Q4 2024 earnings estimates for West Pharmaceutical ...
Brokers Offer Predictions for Alimera Sciences, Inc.’s Q2 2024 Earnings (NASDAQ:ALIM)
ETF DAILY NEWS· 6 hours agoAlimera Sciences, Inc. (NASDAQ:ALIM – Free Report) – Equities research analysts at HC Wainwright issued their Q2 2024 earnings per share (EPS) estimates for shares of Alimera ...
HC Wainwright Weighs in on Arrowhead Pharmaceuticals, Inc.’s FY2028 Earnings (NASDAQ:ARWR)
ETF DAILY NEWS· 5 days agoPharmaceuticals in a research report issued to clients and investors on Monday, May 13th. HC Wainwright analyst P. Trucchio now anticipates that the biotechnology company ...
Earnings call: Acumen Pharmaceuticals reports progress in ALTITUDE-AD study By Investing.com
Investing.com· 7 days agoAcumen Pharmaceuticals, in its Q1 2024 earnings call, detailed the initiation of the ALTITUDE-AD...
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call Transcript
Guru Focus· 6 days agoMay 14, 2024 / 08:30PM GMTOperator Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals first quarter 2024 earnings conference call. At this ti
Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Cut to $3.00 by Analysts at Mizuho
ETF DAILY NEWS· 6 days agoAmylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its target price trimmed by Mizuho from $4.00 to $3.00 in a report released on Tuesday morning, Benzinga reports. A ...
Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?
InvestorPlace· 6 days agoVirpax Pharmaceuticals (NASDAQ:VRPX) stock is down on Wednesday as the preclinical-stage ...
Biocryst Pharmaceuticals exec buys $175.8k in stock By Investing.com
Investing.com· 6 days agoIn a recent transaction, Helen M. Thackray, Chief R&D Officer of Biocryst Pharmaceuticals Inc....
Leerink Partnrs Research Analysts Increase Earnings Estimates for ACADIA Pharmaceuticals Inc....
ETF DAILY NEWS· 6 days agoLeerink Partnrs analyst M. Goodman now forecasts that the biopharmaceutical company will post earnings per share of $1.60 for the year, up from their prior forecast of $1.42 ...